• Home
• About
• Login
• Register
• Search
• Current
• Archives
• Announcements
• Books For Review
• Manuscript Submission
• Editorial Review Board
• Permissions and Licensing
• Advertising Information
• Library Referral Form
• Reprints
• Register
• Subscription Information
• Call for Papers - Legal and Regulatory aspects of Opioids
• Privacy
• Special Issue on Buprenophine
• User License Agreement
• BUPE2021

Open Access  Subscription or Fee Access

Table of Contents

Articles

Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users Naama Levy-Cooperman, PhD, Kerri A. Schoedel, PhD, Joseph L. Reiz, BSc, David Thompson, PhD, Bijan Chakaraborty, MStat, Pierre Geoffroy, MD, Kenneth J. Michalko, PharmD, MBA

PDF 165-180

Effect of preoperative intravenous oxycodone on sufentanil consumption after laparoscopic radical gastrectomy Jinguo Wang, MD, PhD, Yaowen Fu, MD, PhD, Honglan Zhou, MD, PhD, Na Wang, MD, PhD

PDF 181-185

Effectiveness and tolerability of tapentadol sustained release in the Australian setting Marc A. Russo, MBBS, DA(UK), FANZCA, FFPMANZCA, Danielle M. Santarelli, PhD

PDF 187-196

Fentanyl in a pectin gel treating breakthrough pain Borja Mugabure Bujedo, MD, Brynjar Karlsson, PhD

PDF 197-203

Acceptability of the use of cellular telephone and computer pictures/video for “pill counts” in buprenorphine maintenance treatment Christopher Welsh, MD

PDF 217-220

Review Articles

Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting Kelly R. Peck, MA, Jennifer Harman Ehrentraut, PhD, Doralina L. Anghelescu, MD

PDF 205-216

ICOO Conference Information

International Conference on Opioids, June 5-7, 2016

PDF 221-228